The Role of Circulating Tumor (ct)DNA Testing/Monitoring in Stage II-III Colorectal Cancer

February 15, 2021
Christopher Lieu, MD, Anschutz Medical Campus

,
Sepideh Gholami, MD, FACS, UC Davis Comprehensive Cancer Center

Two experts in the management of colorectal cancer discuss the evolving role of circulating tumor (ct)DNA testing/monitoring in stage II and III disease.



x